drugset / Trial / NCT02535949
Tranexamic Acid Mechanisms and Pharmacokinetics in Traumatic Injury
Phase 2
Completed
150 enrolled
Washington University School of Medicine
United States Department of Defense · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the effects of TXA on the immune system, its pharmacokinetics, as well as safety and efficacy in severely injured trauma patients.
Timeline
- Start
- 2016-02
- Primary completion
- 2017-07-04
- Completion
- 2017-07-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 2 g | Intravenous |
| Subject | Tranexamic Acid | Small molecule | 4 g | Intravenous |